The Interim Director ensures that reconciliation of controlled substance returns to pharmacy stock is performed during controlled substance inspections and monitors compliance.
Questioned Costs
$0
Funds for Better Use
$0
Recommendation Status
Closed
Source UUID
18-00620-277-7
Report
Recommendation Number
7
Significant Recommendation
Yes